Protagonist Therapeutics (PTGX) Exchange Rate Effect (2015 - 2022)
Protagonist Therapeutics' (PTGX) quarterly Exchange Rate Effect came in at $75000.0 in Q4 2022, up 240.91% year-on-year from $22000.0 in Q4 2021, and up 142.86% quarter-over-quarter from -$175000.0 in Q3 2022.
Protagonist Therapeutics (PTGX) Exchange Rate Effect (2015 - 2022) Analysis & Trends
Protagonist Therapeutics has disclosed Exchange Rate Effect across 8 years of filings, most recently posting $75000.0 for Q4 2022.
- Exchange Rate Effect for Q4 2022 came in at $75000.0, up 240.91% year-over-year; the trailing twelve-month figure through Dec 2022 was -$90000.0 (up 28.57% YoY), and the FY2022 annual result was -$90000.0, up 28.57% from the prior year.
- Exchange Rate Effect came in at $75000.0 for Q4 2022 at Protagonist Therapeutics, up from -$175000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $123000.0 in Q3 2020 to a low of -$175000.0 in Q3 2022.
- The 5-year median for Exchange Rate Effect is -$14000.0 (2019), against an average of -$14666.7.
- Peak annual rise in Exchange Rate Effect reached 1244.44% in 2020, while the deepest fall reached 1000.0% in 2020.
- Protagonist Therapeutics' Exchange Rate Effect stood at -$87000.0 in 2018, then sank by 43.68% to -$125000.0 in 2019, then surged by 116.8% to $21000.0 in 2020, then grew by 4.76% to $22000.0 in 2021, then jumped by 240.91% to $75000.0 in 2022.
- The last three Exchange Rate Effect figures came in at $75000.0 (Q4 2022), -$175000.0 (Q3 2022), and -$19000.0 (Q2 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Protagonist Therapeutics | 7.35 Bn | 7.35 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 75,000.00 |
| Dec 31, 2022 | 75,000.00 |
| Sep 30, 2022 | -175,000.00 |
| Sep 30, 2022 | -175,000.00 |
| Jun 30, 2022 | -19,000.00 |
| Jun 30, 2022 | -19,000.00 |
| Mar 31, 2022 | 29,000.00 |
| Mar 31, 2022 | 29,000.00 |
| Dec 31, 2021 | 22,000.00 |
| Dec 31, 2021 | 22,000.00 |
| Sep 30, 2021 | -74,000.00 |
| Sep 30, 2021 | -74,000.00 |
| Jun 30, 2021 | -51,000.00 |
| Jun 30, 2021 | -51,000.00 |
| Mar 31, 2021 | -23,000.00 |
| Mar 31, 2021 | -23,000.00 |
| Dec 31, 2020 | 21,000.00 |
| Dec 31, 2020 | 21,000.00 |
| Sep 30, 2020 | 123,000.00 |
| Sep 30, 2020 | 123,000.00 |